If everything goes as planned, this week will be the busiest for initial public offerings since 2000.
VIDEO ON MSN MONEY
Most investors in the precious metal should avoid ETFs and focus instead on these picks.
Seasonally, gold is often ho-hum during the first six months of the year, only to set a low in July and extend strongly on the up side into October.
If I were short, I'd be anxious about the next "black swan" event that could propel gold suddenly higher. I'd also be apprehensive about that seasonal strength and concerned that there is an important cyclical low due right about now.
Agricultural plays and gun makers are performing exceptionally well right now.
By Kate Stalter, MoneyShow.com
In this interview, investing coach Gennady Kupershteyn shares some ideas for sectors showing technical and fundamental strength. In addition to some agricultural stocks, he discusses tech, health care, gun makers, and consumer discretionary names.
Kate Stalter: Today, I'm speaking with one of our frequent guests here on the Daily Guru, Gennady Kupershteyn of Capitalist Bull.
Though this time, the $740 mark from UBS seems reasonable -- in two years.
By Jeff Reeves
I know, I know -- more nonsense about Apple price targets. These things are the hype machine of tech analysts and frequently are just silly figures to get attention.
Stocks have been sliding after a dramatic end-of-June surge. Here's why the uptrend isn't finished yet.
Stocks have been suffering bouts of panic selling over the past few days as concerns about the future of the new plan to use eurozone bailout funds to directly recapitalize weak banks (such as those in Spain) dampened spirits. German ratification of the plan will be delayed by the country's constitutional court for as long as three months, according to reports in Der Spiegel.
Some better industrial production data out of Europe and rumors of additional policy easing by the People's Bank of China weren't enough to overcome those worries. Have the four consecutive losses (with a fifth possible on Wednesday) opened the door to a new medium-term downtrend? Or is this merely a buying dip within a larger uptrend?
Stocks are mixed as investors await the release of minutes from June's Federal Reserve meeting.
Fertilizer stocks, including Potash Corp. (POT), Mosaic (MOS) and CF Industries (CF), moved up modestly after the USDA slashed its forecast for corn yields.
Goldcorp (GG) slumped nearly 10% after the company reported lower than expected second-quarter gold production and reduced its full-year production guidance. Its announcement weighed a bit on peers, including Barrick Gold (ABX), Newmont Mining (NEM) and Yamana Gold (AUY).
Despite introducing new merchandising and pricing policies, the retailer continues to stumble.
Amazon's tablet made a splashy entrance and even managed to eat into the iPad's wide lead. But could the e-tail giant do the same with a smartphone?
First came the Kindle Fire. Now Amazon (AMZN) is reportedly working with manufacturer Foxconn to develop its own smartphone, which would presumably take a cue from the Seattle-based e-tailer's popular line of Kindle tablets. The move is seen as Amazon's attempt to upset Apple (AAPL) and Google's (GOOG) goals in the digital content market by locking consumers into its robust catalog of e-books, movies, and mp3s -- even though the phone will likely run on something similar to the already-established Android platform.
But while the low-cost Kindle Fire was a rousing success, critics say that building a smartphone is an entirely different kind of beast, and Amazon would be wise to stay away.
Allegiant Travel is upgraded to 'buy,' and Dendreon is downgraded to 'underperform.'
Wednesday's noteworthy upgrades include:
Coca-Cola will be the first blue chip since 2005 to divide its shares. What are splits, and why should investors care?
It's stupid. If you own 10 shares at $40, or one share at $400, it's the same thing! You just need to know how to divide.
In light of his oft-cited quotation above, it was more than a little ironic to see Google's (GOOG) co-founder recently reverse himself and back the search giant's first stock split since it went public eight years ago. Page had nothing to say regarding his about-face, having conveniently lost his voice for the occasion, but the de facto 2-for-1 split was especially contentious, as it effectively consolidated his power, involving as it did the creation of a Class C stock that is devoid of voting rights.
Page is not the only high-profile investor to speak out on stock splits. None other than Warren Buffett rhetorically asked shareholders in a 1983 letter: "Could we really improve our . . . group by trading some present clear-thinking members for impressionable new ones who, preferring paper to value, feel wealthier with nine $10 bills than with one $100 bill?"
One of the stronger long-term stocks has sharply lowered its guidance, which means we could see a rash of it over the next few weeks.
By Jim Jubak, MoneyShow.com
This is what I'm afraid second-quarter earnings season is going to look like for even the best of companies: On Tuesday, Cummins (CMI) lowered its guidance for second-quarter revenue to $4.45 billion. The Wall Street consensus was $5.07 billion in revenue before the announcement.
For the full 2012 year, the company said it now expects that revenue will be flat with 2011. The company had hung tough until today, saying previously that it expected revenue to grow 10% in 2012 from last year.
The move is a big bet that states will allow for Medicaid expansion.
When news broke on Monday that WellPoint (WLP) would buy the Medicaid-focused insurer Amerigroup (AGP) for $4.9 billion, the deal sent shock waves through the health care industry -- and AGP shares rose 38%.
By acquiring AGP at the premium price of $92 a share, WellPoint (whose shares rose about 3% on the news) is going all-in on the government-sponsored managed care market.
If a stock is up 500% in a straight line, that's a clue.
I stumbled onto a cult of true believers these last few days, not unlike the cult behind Dendreon (DNDN), the last hornet's nest I tried to navigate, and I think the consequences will be similar for both the hornets and me.
I'm talking about Arena Pharmaceuticals (ARNA), the company that has the first new diet pill approval in more than a decade.
The manufacturer of permanent birth control system announced its next-generation procedure.
By Zacks Equity Research
Conceptus (CPTS), the manufacturer of permanent birth control system, Essure, recently announced a 60-patient clinical trial with its next-generation Essure procedure. Patient enrollment for the clinical trial has just begun in the company's two medical centers in Canada and Mexico.
The existing Essure procedure does not immediately provide permanent birth control. It instead requires the patient to wait for a period of 90 days, during which the body grows over the inserted device, thus forming a barrier that prevents the entry of sperm. Therefore, during this 90-day period there is a need to use some other form of contraceptive.
UBS initiates the iPhone maker with a 'buy,' and the bank is reportedly planning to reclaim stock compensation from executives involved in the trading scandal.
By Michael Baron, TheStreet.com
UBS initiated coverage of Apple with a "buy" rating and a 12-month price target of $740, saying it sees the release of the iPhone 5 as another positive catalyst for the stock, which it views as being reasonably priced.
"Apple is creating a tech empire that likely has not reached its zenith," the firm said. "Our Wave Principle teaches that empires don't last. We recommend the stock, however, because the relatively low valuation seems to discount a too-pessimistic future given moderate smartphone and tablet penetration as well as potential new products."
Behind the usual public relations waffle there are real benefits for both partners.
"Strategic alliances" in business often come to nothing more than a few dutiful emails floating between office cubicles. This is especially true when no cash changes hands, or when they're created to put an end to a legal dispute that one side didn't want and the other regrets.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
In this economy, you'd think these retailers would be racking up the sales. That's not the case.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] Range-bound action continues with the S&P 500 (-0.1%) holding near its unchanged level. Meanwhile, the tech-heavy Nasdaq (+0.2%) outperforms.
The Nasdaq has been able to stay ahead of the S&P 500 throughout the session thanks to the relative strength of the technology sector (+0.1%). High-beta chipmakers also outperform, but the PHLX Semiconductor Index has narrowed its gain to 0.1% after being up 0.7% shortly after the start of the session.
Furthermore, ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|